The Challenges of Harmonising Device Classification
This article was originally published in RAJ Devices
The publication of final Global Harmonization Task Force guidance on the principles of medical device classification and conformity assessment (see pages 357-358) marks a significant milestone on the road to harmonisation. If the recommendations in the two documents1,2 are followed, the diversity of classification and conformity assessment schemes worldwide will decrease.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.